Nicholas Stock

710 citations

28 papers · 611 indexed · h-index 14

Impact in

Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology

Papers in

Pharmacology 9
- Inflammatory mediators and NSAID effects 7
Physiology 10
- Asthma and respiratory diseases 8

Co-authors: Christopher D. King Peppi Prasit Marie L. Smith Anthony G. M. Barrett Thomas S. Reger Gretchen Bain John C. Head Lucia Correa
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (2 papers)European Journal of Pharmacology (2 papers)The Journal of Organic Chemistry (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: United States Canada United Kingdom

In The Last Decade

Nicholas Stock

27 papers receiving 565 citations

Peers

Countries citing papers authored by Nicholas Stock

Since Specialization

Citations

This map shows the geographic impact of Nicholas Stock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Stock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Stock more than expected).

Fields of papers citing papers by Nicholas Stock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Stock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Stock. The network helps show where Nicholas Stock may publish in the future.

Co-authors

The 25 scholars most cited alongside Nicholas Stock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicholas Stock Line = papers co-authored together Nicholas Stock links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies Bioorganic & Medicinal Chemistry Letters ·Jason Jacintho, Christopher Baccei, Gladston Thalles da Silva, Wafa AI Baluki, Austin Chen, Lucia Correa, Gislane Bernardino Freitas, Bryan Laffitte, Catherine Lee, Daniel S. Lorrain, Davorka Messmer, Peppi Prasit, Karin J. Stebbins, Nicholas Stock	2018	7
2	In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist European Journal of Pharmacology ·Karin J. Stebbins, Wafa AI Baluki, Sandrine Lauriane Ndjoulou Badiana, Lucia Correa, Davorka Messmer, Richard A. Bundey, Christopher Baccei, Gladston Thalles da Silva, Austin Chen, Nicholas Stock, Peppi Prasit, Daniel S. Lorrain	2017	25
3	A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo Molecular Medicine ·Davorka Messmer, R. H. Gupta, Karin J. Stebbins, Gladston Thalles da Silva, Nicholas Stock, Sandrine Lauriane Ndjoulou Badiana, Lucia Correa, Austin Chen, Jason Jacintho, Nicholas Chiorazzi, Xiao‐Jie Yan, David Spaner, Peppi Prasit, Daniel S. Lorrain	2015	36
4	Identification of the first potent, selective and bioavailable PPARα antagonist Bioorganic & Medicinal Chemistry Letters ·Gladston Thalles da Silva, Christopher Baccei, Wafa AI Baluki, Richard A. Bundey, Austin Chen, María Paula Botero, Lucia Correa, Jason Jacintho, Daniel S. Lorrain, Davorka Messmer, Karin J. Stebbins, Peppi Prasit, Nicholas Stock	2014	9
5	Inhibition of Fatty Acid Oxidation Leads to Apoptosis of Resting and Proliferating Chronic Lymphocytic Leukemia Cells in Vitro Blood ·Davorka Messmer, R. H. Gupta, Gladston Thalles da Silva, Nicholas Stock, Richard A. Bundey, Lucia Correa, de Grally, Karin J. Stebbins, Sandrine Lauriane Ndjoulou Badiana, Austin Chen, Jason Jacintho, David Spaner, Peppi Prasit, Daniel S. Lorrain	2012	1
6	Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor British Journal of Clinical Pharmacology ·Gretchen Bain, Christopher D. King, Oliver Kröner, Nora Wuttke, Virginia Norris, Claire Ambery, J. Bentley, M. Yamada, Angelina M. Santini, Jeroen van de Wetering de Rooij, Nicholas Stock, 陈仲沪, John H. Hutchinson, Jilly F. Evans	2012	19
7	5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- tert -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor Journal of Medicinal Chemistry ·Nicholas Stock, Gretchen Bain, 陈仲沪, Yiwei Li, D. Wabeke, Jeffrey Roppe, Angelina M. Santini, Janice Darlington, Pat Prodanovich, Christopher D. King, Christopher Baccei, Catherine Lee, Haojing Rong, Charles W. Chapman, Wafa AI Baluki, Suk-Bum Yoon, Lucia Correa, John H. Hutchinson, Jilly F. Evans, Peppi Prasit	2011	39
8	Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): A potent, selective prostaglandin D2 receptor antagonist Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Deborah L. Volkots, Karin J. Stebbins, Wafa AI Baluki, Brian A. Stearns, Jeffrey Roppe, Tim Parr, Christopher Baccei, Gretchen Bain, Charles W. Chapman, Lucia Correa, Janice Darlington, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Pat Prodanovich, Angelina M. Santini, Jilly F. Evans, John H. Hutchinson, Peppi Prasit	2010	9
9	Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation European Journal of Pharmacology ·Daniel S. Lorrain, Gretchen Bain, Lucia Correa, Charles W. Chapman, Wafa AI Baluki, Angelina M. Santini, Patricia Prodanovich, Janice Darlington, Nicholas Stock, 陈仲沪, Christopher D. King, Catherine Lee, Christopher Baccei, Brian A. Stearns, Jeffrey Roppe, John H. Hutchinson, Peppi Prasit, Jilly F. Evans	2010	19
10	5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—A potent FLAP inhibitor suitable for topical administration Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Christopher Baccei, Gretchen Bain, Charles W. Chapman, Lucia Correa, Janice Darlington, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Pat Prodanovich, Angelina M. Santini, Oliver Kröner, Jilly F. Evans, John H. Hutchinson, Peppi Prasit	2010	12
11	Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis Bioorganic & Medicinal Chemistry Letters ·Brian A. Stearns, Christopher Baccei, Gretchen Bain, Wafa AI Baluki, G. Trompetti, Heather Coate, Jilly F. Evans, Patrick Fagan, John H. Hutchinson, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Peppi Prasit, Pat Prodanovich, Angelina M. Santini, 重典三浦, Nicholas Stock, Jarese Micah Echiverria Lomantas	2009	37
12	Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists Bioorganic & Medicinal Chemistry Letters ·Thomas S. Reger, 陈仲沪, Nicholas Stock, Bowei Wang, Nicholas D. Smith, Benito Muñoz, Mitchell D. Green, Michael F. Gardner, Joyce James, Weichao Chen, Pavlína Musilová, Qian Si, H.M. Singleton, Russell B. Lingham, Richard A. Mumford	2009	7
13	Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3′,5′-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist Bioorganic & Medicinal Chemistry Letters ·Shankar Venkatraman, Alec D. Lebsack, Pavlína Musilová, Michael F. Gardner, Joyce James, Russell B. Lingham, Salony Maniar, Richard A. Mumford, Qian Si, Nicholas Stock, H.M. Singleton, Bowei Wang, 陈仲沪, Benito Muñoz	2009	6
14	5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—A potent FLAP inhibitor Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Christopher Baccei, Gretchen Bain, Wafa AI Baluki, Charles W. Chapman, Janice Darlington, Christopher D. King, Catherine Lee, Yiwei Li, Daniel S. Lorrain, Pat Prodanovich, Haojing Rong, Angelina M. Santini, 陈仲沪, Jilly F. Evans, John H. Hutchinson, Peppi Prasit	2009	20
15	Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung Journal of Pharmacology and Experimental Therapeutics ·Karin J. Stebbins, Wafa AI Baluki, Christopher Baccei, 重典三浦, Jarese Micah Echiverria Lomantas, Heather Coate, Nicholas Stock, Angelina M. Santini, Patrick Fagan, Patricia Prodanovich, Gretchen Bain, Brian A. Stearns, Christopher D. King, John H. Hutchinson, Peppi Prasit, Jilly F. Evans, Daniel S. Lorrain	2009	40
16	The geminal dimethyl analogue of Flurbiprofen as a novel Aβ42 inhibitor and potential Alzheimer’s disease modifying agent Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Benito Muñoz, Jonathan D.J. Wrigley, Mark S. Shearman, Dirk Beher, Samuel Njoroge, Toni Williamson, Gretchen Bain, Weichao Chen, Xiaohui Jiang, Hans F. M. Reijnders, Peppi Prasit	2006	19
17	Novel approach to pro-drugs of lactones: water soluble imidate and ortho-ester derivatives of a furanone-based COX-2 selective inhibitor Bioorganic & Medicinal Chemistry Letters ·Steve F. Poon, Nicholas Stock, Joseph E. Payne, R. B. Goldina, Brian A. Stearns, Xiaoqing Yang, Weichao Chen, Benito Muñoz, Nicholas D. Smith	2005	7
18	Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia Bioorganic & Medicinal Chemistry Letters ·Nicholas D. Smith, Thomas S. Reger, Joseph E. Payne, 陈仲沪, Suk-Bum Yoon, J.A. Den Engelse, Nicholas Stock, Merryl Cramer, Weichao Chen, Jennifer Yang, Peppi Prasit, Benito Muñoz	2005	3
19	N-Acridin-9-yl-butane-1,4-diamine derivatives: high-affinity ligands of the α2δ subunit of voltage gated calcium channels Bioorganic & Medicinal Chemistry Letters ·Jongwon Lim, Nicholas Stock, Richard Pracitto, Elena Tadeo, Benito Muñoz, Ashok Chaudhary, Angelina M. Santini, Luying Zeng, Hervé Schaffhauser, Peter A. Davis, Jayashree Aiyar, Shankar Venkatraman	2004	10
20	Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms Archives of Biochemistry and Biophysics ·Xinming Cui, Mitchell Green, Nicholas Stock, Thomas S. Reger, 陈仲沪, Christopher D. King	2004	96

About Nicholas Stock

Nicholas Stock is a scholar working on Pharmacology, Physiology, Pharmacology, Biochemistry and Cancer Research, having authored 28 papers that have together received 611 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (8 papers), Inflammatory mediators and NSAID effects (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (3 papers), Synthesis and Biological Evaluation (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Pharmacology (72 citations), Pharmacology (138 citations), Biochemistry (51 citations), Organic Chemistry (187 citations) and Physiology (146 citations). Nicholas Stock has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Christopher D. King, Peppi Prasit, Marie L. Smith, Anthony G. M. Barrett, Thomas S. Reger, Gretchen Bain, John C. Head, Lucia Correa, Andrew J. P. White and Mitchell Green. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, European Journal of Pharmacology, The Journal of Organic Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact